Pharvaris (PHVS) EPS (Basic) (2020 - 2026)

Pharvaris (PHVS) reported EPS (Basic) of -$0.05 for Q1 2026, up 99.31% on a YoY basis from -$0.02 in Q1 2025, and up 77.57% quarter-over-quarter from -$0.22 in Q4 2025.

Pharvaris (PHVS) EPS (Basic) (2020 - 2026) Analysis & Trends

Pharvaris has reported EPS (Basic) for 7 years, with the latest figure at -$0.05 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 99.31% year-over-year to -$0.05; the trailing twelve-month figure through Mar 2026 stood at $6.65 (down 99.98% YoY), and the FY2025 full-year result was -$3.36, down 25.01% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.05, up from -$0.22 in the prior quarter.
  • The five-year high for EPS (Basic) was $27766.3 in Q2 2024, with the low at -$9.49 in Q4 2022.
  • Historically, EPS (Basic) has averaged $2622.3 across 5 years, with a median of -$0.07 in 2023.
  • Annual changes were most pronounced in 2023 — EPS (Basic) soared 38178382.1% — and 2024, when it tumbled 9553.52%.
  • Pharvaris' EPS (Basic) stood at -$9.49 in 2022, then jumped by 46.46% to -$5.08 in 2023, then fell by 1.53% to -$5.16 in 2024, then soared by 95.75% to -$0.22 in 2025, then jumped by 77.57% to -$0.05 in 2026.
  • The last three EPS (Basic) figures came in at -$0.05 (Q1 2026), -$0.22 (Q4 2025), and -$0.05 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -0.68
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 3.06
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 0.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 0.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 0.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 0.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 4.06
9 Abivax 90.15 Bn 90.15 Bn - -0.06
10 Pharvaris 28.66 Bn 28.37 Bn - -0.05

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.05
Dec 31, 2025 -0.22
Sep 30, 2025 -0.05
Jun 30, 2025 6.96
Mar 31, 2025 -7.11
Dec 31, 2024 -5.16
Sep 30, 2024 -6.42
Jun 30, 2024 27,766.32
Mar 31, 2024 -4.33
Dec 31, 2023 -5.08
Sep 30, 2023 -0.07
Jun 30, 2023 16,843.27
Mar 31, 2023 -0.08
Dec 31, 2022 -9.49
Sep 30, 2022 -0.03
Jun 30, 2022 0.04
Mar 31, 2022 -0.06
Dec 31, 2021 -3.08
Sep 30, 2021 -0.03
Jun 30, 2021 0.05